A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis

被引:7
|
作者
Suarez, Miguel [1 ,2 ]
Martinez, Raquel [1 ]
Torres, Ana Maria [2 ]
Torres, Beatriz [3 ]
Mateo, Jorge [2 ]
机构
[1] Virgen Luz Hosp, Gastroenterol Dept, Ave Hermandad Donantes Sangre 1, Cuenca 16002, Spain
[2] Univ Castilla La Mancha, Inst Technol, Med Anal Expert Grp, Cuenca, Spain
[3] Obispo Polanco Hosp, Teruel, Spain
关键词
Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Liver fibrosis; Machine learning; DISEASE; CLASSIFICATION; PREVALENCE;
D O I
10.1007/s10620-023-08031-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimNonalcoholic fatty liver disease (NAFLD) is a silent epidemy that has become the most common chronic liver disease worldwide. Nonalcoholic steatohepatitis (NASH) is an advanced stage of NAFLD, which is linked to a high risk of cirrhosis and hepatocellular carcinoma. The aim of this study is to develop a predictive model to identify the main risk factors associated with the progression of hepatic fibrosis in patients with NASH.MethodsA database from a multicenter retrospective cross-sectional study was analyzed. A total of 215 patients with NASH biopsy-proven diagnosed were collected. NAFLD Activity Score and Kleiner scoring system were used to diagnose and staging these patients. Noninvasive tests (NITs) scores were added to identify which one were more reliable for follow-up and to avoid biopsy. For analysis, different Machine Learning methods were implemented, being the eXtreme Gradient Booster (XGB) system the proposed algorithm to develop the predictive model.ResultsThe most important variable in this predictive model was High-density lipoprotein (HDL) cholesterol, followed by systemic arterial hypertension and triglycerides (TG). NAFLD Fibrosis Score (NFS) was the most reliable NIT. As for the proposed method, XGB obtained higher results than the second method, K-Nearest Neighbors, in terms of accuracy (95.05 vs. 90.42) and Area Under the Curve (0.95 vs. 0.91).ConclusionsHDL cholesterol, systemic arterial hypertension, and TG were the most important risk factors for liver fibrosis progression in NASH patients. NFS is recommended for monitoring and decision making.
引用
收藏
页码:3801 / 3809
页数:9
相关论文
共 50 条
  • [1] A Machine Learning Method to Identify the Risk Factors for Liver Fibrosis Progression in Nonalcoholic Steatohepatitis
    Miguel Suárez
    Raquel Martínez
    Ana María Torres
    Beatriz Torres
    Jorge Mateo
    Digestive Diseases and Sciences, 2023, 68 : 3801 - 3809
  • [2] Nonalcoholic steatohepatitis: risk factors for liver fibrosis
    Shimada, M
    Hashimoto, E
    Kaneda, H
    Noguchi, S
    Hayashi, N
    HEPATOLOGY RESEARCH, 2002, 24 (04) : 429 - 438
  • [3] Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
    Hagstrom, Hannes
    Elfwen, Olof
    Hultcrantz, Rolf
    Stal, Per
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [4] Advanced machine learning techniques to identify a panel of biomarkers that identify nonalcoholic steatohepatitis
    Chernbumroong, Saisakul
    Grove, Jane I.
    Astbury, Stuart
    Leeming, Diana J.
    Kaye, Philip
    Antoine, Daniel J.
    Hoad, Caroline
    Francis, Susan
    Guha, Indra Neil
    Miller, Michael
    Dillon, John F.
    Allison, Michael E.
    Aithal, Guruprasad P.
    Garibaldi, Jonathan
    HEPATOLOGY, 2017, 66 : 53A - 54A
  • [5] Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis
    Pelusi, Serena
    Cespiati, Annalisa
    Rametta, Raffaela
    Pennisi, Grazia
    Mannisto, Ville
    Rosso, Chiara
    Baselli, Guido
    Dongiovanni, Paola
    Fracanzani, Anna Ludovica
    Badiali, Sara
    Maggioni, Marco
    Craxi, Antonio
    Fargion, Silvia
    Prati, Daniele
    Nobili, Valerio
    Bugianesi, Elisabetta
    Romeo, Stefano
    Pihlajamaki, Jussi
    Petta, Salvatore
    Valenti, Luca
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (11) : 2310 - +
  • [6] Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation
    Sourianarayanane, Achuthan
    Arikapudi, Sowminya
    McCullough, Arthur J.
    Humar, Abhinav
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (04) : 481 - 487
  • [7] CARDIOVASCULAR RISK FACTORS IN NONALCOHOLIC FATTY LIVER DISEASE/NONALCOHOLIC STEATOHEPATITIS
    Ivanova, R.
    Gospodinova, M.
    Petrova, J.
    Alexiev, A.
    Denchev, S.
    Mateva, L.
    ATHEROSCLEROSIS, 2014, 235 (02) : E240 - E240
  • [8] Liver fibrosis markers of nonalcoholic steatohepatitis
    Hirayuki Enomoto
    Yukihiro Bando
    Hideji Nakamura
    Shuhei Nishiguchi
    Masafumi Koga
    World Journal of Gastroenterology, 2015, 21 (24) : 7427 - 7435
  • [9] Liver fibrosis markers of nonalcoholic steatohepatitis
    Enomoto, Hirayuki
    Bando, Yukihiro
    Nakamura, Hideji
    Nishiguchi, Shuhei
    Koga, Masafumi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (24) : 7427 - 7435
  • [10] Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease
    Pais, R.
    Pascale, A.
    Fedchuck, L.
    Charlotte, F.
    Poynard, T.
    Ratziu, V.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (01) : 23 - 28